Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 82

Related Citations for PubMed (Select 23233023)

1.

Abnormal fatty acid composition in the frontopolar cortex of patients with affective disorders.

Tatebayashi Y, Nihonmatsu-Kikuchi N, Hayashi Y, Yu X, Soma M, Ikeda K.

Transl Psychiatry. 2012 Dec 11;2:e204. doi: 10.1038/tp.2012.132.

2.

Abnormalities in the fatty acid composition of the postmortem entorhinal cortex of patients with schizophrenia, bipolar disorder, and major depressive disorder.

Hamazaki K, Hamazaki T, Inadera H.

Psychiatry Res. 2013 Nov 30;210(1):346-50. doi: 10.1016/j.psychres.2013.05.006. Epub 2013 May 31.

PMID:
23731984
3.

Fatty acid composition in the postmortem amygdala of patients with schizophrenia, bipolar disorder, and major depressive disorder.

Hamazaki K, Hamazaki T, Inadera H.

J Psychiatr Res. 2012 Aug;46(8):1024-8. doi: 10.1016/j.jpsychires.2012.04.012. Epub 2012 May 8.

PMID:
22572570
4.

Proton magnetic resonance spectroscopy of the frontal lobe and cerebellar vermis in children with a mood disorder and a familial risk for bipolar disorders.

Cecil KM, DelBello MP, Sellars MC, Strakowski SM.

J Child Adolesc Psychopharmacol. 2003 Winter;13(4):545-55.

PMID:
14977467
5.

Phospholipid profile in the postmortem hippocampus of patients with schizophrenia and bipolar disorder: no changes in docosahexaenoic acid species.

Hamazaki K, Choi KH, Kim HY.

J Psychiatr Res. 2010 Aug;44(11):688-93. doi: 10.1016/j.jpsychires.2009.11.017. Epub 2010 Jan 6.

6.

Abnormal fatty acid pattern in the superior temporal gyrus distinguishes bipolar disorder from major depression and schizophrenia and resembles multiple sclerosis.

McNamara RK, Rider T, Jandacek R, Tso P.

Psychiatry Res. 2014 Mar 30;215(3):560-7. doi: 10.1016/j.psychres.2013.12.022. Epub 2014 Jan 2.

PMID:
24439517
7.

Selective deficits in the omega-3 fatty acid docosahexaenoic acid in the postmortem orbitofrontal cortex of patients with major depressive disorder.

McNamara RK, Hahn CG, Jandacek R, Rider T, Tso P, Stanford KE, Richtand NM.

Biol Psychiatry. 2007 Jul 1;62(1):17-24. Epub 2006 Dec 22.

PMID:
17188654
8.

Disease-specific alterations in frontal cortex brain proteins in schizophrenia, bipolar disorder, and major depressive disorder. The Stanley Neuropathology Consortium.

Johnston-Wilson NL, Sims CD, Hofmann JP, Anderson L, Shore AD, Torrey EF, Yolken RH.

Mol Psychiatry. 2000 Mar;5(2):142-9.

PMID:
10822341
9.

Neural stem cell proliferation is decreased in schizophrenia, but not in depression.

Reif A, Fritzen S, Finger M, Strobel A, Lauer M, Schmitt A, Lesch KP.

Mol Psychiatry. 2006 May;11(5):514-22.

PMID:
16415915
10.

Neurochemical markers for schizophrenia, bipolar disorder, and major depression in postmortem brains.

Torrey EF, Barci BM, Webster MJ, Bartko JJ, Meador-Woodruff JH, Knable MB.

Biol Psychiatry. 2005 Feb 1;57(3):252-60.

PMID:
15691526
12.

[Hyperthymic and depressive temperaments study in controls, as a function of their familial loading for mood disorders].

Chiaroni P, Hantouche EG, Gouvernet J, Azorin JM, Akiskal HS.

Encephale. 2004 Nov-Dec;30(6):509-15. French.

PMID:
15738852
13.

Evaluation of docosahexaenoic acid deficiency as a preventable risk factor for recurrent affective disorders: current status, future directions, and dietary recommendations.

McNamara RK.

Prostaglandins Leukot Essent Fatty Acids. 2009 Aug-Sep;81(2-3):223-31. doi: 10.1016/j.plefa.2009.05.017. Epub 2009 Jun 9. Review.

PMID:
19515544
14.

Reductions in cholesterol and synaptic markers in association cortex in mood disorders.

Beasley CL, Honer WG, Bergmann K, Falkai P, L├╝tjohann D, Bayer TA.

Bipolar Disord. 2005 Oct;7(5):449-55.

PMID:
16176438
15.

Neuropathological similarities and differences between schizophrenia and bipolar disorder: a flow cytometric postmortem brain study.

Hayashi Y, Nihonmatsu-Kikuchi N, Hisanaga S, Yu XJ, Tatebayashi Y.

PLoS One. 2012;7(3):e33019. doi: 10.1371/journal.pone.0033019. Epub 2012 Mar 15.

16.

Metabonomic analysis identifies molecular changes associated with the pathophysiology and drug treatment of bipolar disorder.

Lan MJ, McLoughlin GA, Griffin JL, Tsang TM, Huang JT, Yuan P, Manji H, Holmes E, Bahn S.

Mol Psychiatry. 2009 Mar;14(3):269-79. doi: 10.1038/sj.mp.4002130. Epub 2008 Feb 5.

PMID:
18256615
17.

Increased levels of glutamate in brains from patients with mood disorders.

Hashimoto K, Sawa A, Iyo M.

Biol Psychiatry. 2007 Dec 1;62(11):1310-6. Epub 2007 Jun 15.

PMID:
17574216
18.
19.

Omega-3 fatty acids and mood disorders.

Parker G, Gibson NA, Brotchie H, Heruc G, Rees AM, Hadzi-Pavlovic D.

Am J Psychiatry. 2006 Jun;163(6):969-78. Review. Erratum in: Am J Psychiatry. 2006 Oct;163(10):1842.

PMID:
16741195
20.

Myelin staining of deep white matter in the dorsolateral prefrontal cortex in schizophrenia, bipolar disorder, and unipolar major depression.

Regenold WT, Phatak P, Marano CM, Gearhart L, Viens CH, Hisley KC.

Psychiatry Res. 2007 Jun 30;151(3):179-88. Epub 2007 Apr 11.

PMID:
17433451
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk